Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.
TRUSTransrectal ultrasonography, see there.
ultrasound(ul'tra-sownd?) [ ultra- + sound]
continuous wave ultrasound
continuous wave Doppler ultrasound
duplex Doppler ultrasound
endobronchial ultrasoundAbbreviation: EBUS
endorectal ultrasoundAbbreviation: ERUS
endovaginal ultrasoundTransvaginal ultrasonography.
high-intensity focused ultrasoundAbbreviation: HIFU
intravascular ultrasoundAbbreviation: IVUS
keepsake fetal ultrasound
pulsed-wave Doppler ultrasound, pulsed Doppler ultrasound
quantitative ultrasoundAbbreviation: QUS
time-motion mode ultrasoundM-mode ultrasound.
transrectal ultrasoundAbbreviation: TRUS
transrectal ultrasoundAbbreviation: TRUS
Ultrasound, Prostate (Transrectal)
Area of applicationProstate, seminal vesicles.
ContrastDone without contrast.
Prostate US is used to evaluate the structure, size, and position of the contents of the prostate (e.g., masses). This procedure can evaluate abnormal pathology in prostate tissue, the seminal vesicles, and surrounding perirectal tissue. Prostate US aids in the diagnosis of prostatic cancer by evaluating palpable nodules as a complement to a digital rectal examination (DRE) or in response to an elevated PSA level. The DRE is a simple procedure used to examine, by palpation, the lower rectum and prostate gland. It is performed by the health-care provider (HCP) who inserts a lubricated, gloved finger into the rectum while the patient is properly positioned. Prostate US can also be used to stage carcinoma and to assist in radiation seed placement. Micturition disorders can also be evaluated by this procedure. The examination is helpful in monitoring patient response to therapy for prostatic disease.
This procedure is contraindicated for
- Aid in the diagnosis of micturition disorders
- Aid in prostate cancer diagnosis
- Assess prostatic calcifications
- Assist in guided needle biopsy of a suspected tumor
- Assist in radiation seed placement
- Determine prostatic cancer staging
- Detect prostatitis
- Normal size, consistency, and contour of the prostate gland
Abnormal findings related to
- Benign prostatic hypertrophy or hyperplasia
- Micturition disorders
- Perirectal abscess
- Perirectal tumor
- Prostate abscess
- Prostate cancer
- Rectal tumor
- Seminal vesicle tumor
Factors that may impair clear imaging
- Attenuation of the sound waves by pelvic bones, which can impair clear imaging of the prostate
- Incorrect placement of the transducer over the desired test site; quality of the US study is very dependent upon the skill of the ultrasonographer
- Metallic objects (e.g., jewelry, body rings) within the examination field, which may inhibit organ visualization and cause unclear images
- Inability of the patient to cooperate or remain still during the procedure because of age, significant pain, or mental status
- Gas or feces in the gastrointestinal tract resulting from inadequate cleansing before the study
- Retained barium from a previous radiological procedure
- Failure to follow pretesting preparations may cause the procedure to be canceled or repeated.
Nursing Implications and Procedure
- Positively identify the patient using at least two unique identifiers before providing care, treatment, or services.
- Patient Teaching: Inform the patient this procedure can assist in evaluating the prostate gland.
- Obtain a history of the patient’s complaints or clinical symptoms, including a list of known allergens, especially allergies or sensitivities to latex.
- Obtain a history of the patient’s genitourinary system, symptoms, and results of previously performed laboratory tests and diagnostic and surgical procedures.
- Note any recent procedures that can interfere with test results (i.e., barium procedures, surgery, or biopsy). There should be 24 hr between administration of barium and this test.
- Colonoscopy and computed tomography of the abdomen, if ordered, should be scheduled after this procedure.
- Obtain a list of the patient’s current medications, including herbs, nutritional supplements, and nutraceuticals (see Effects of Natural Products on Laboratory Values online at DavisPlus).
- Review the procedure with the patient. Address concerns about pain related to the procedure and explain that some pain may be experienced during the test, and there may be moments of discomfort. Inform the patient that the procedure is performed in a US department by a health-care provider (HCP) who specializes in this procedure, with support staff, and takes approximately 30 to 60 min.
- Inform the patient that a small volume enema will be administered prior to the procedure to help remove gas or feces that could interfere with the rectal probe; after the enema a sterile latex- or sheath-covered probe will be inserted into the rectum.
- Sensitivity to social and cultural issues, as well as concern for modesty, is important in providing psychological support before, during, and after the procedure.
- Note that there are no food or fluid restrictions unless by medical direction. The patient may be asked to restrict anticoagulants, aspirin and other salicylates by medical direction for the appropriate number of days prior to the procedure, especially if it is anticipated that a biopsy will be performed.
- Potential complications: N/A
- Observe standard precautions, and follow the general guidelines in Patient Preparation and Specimen Collection. Positively identify the patient.
- Instruct the patient to void and change into the gown, robe, and foot coverings provided.
- Avoid the use of equipment containing latex if the patient has a history of allergic reaction to latex.
- Instruct the patient to cooperate fully and to follow directions. Ask the patient to remain still throughout the procedure because movement produces unreliable results.
- Place the patient on the examination table on his left side with his knees bent toward the chest; other positions may be used during the examination.
- Expose the rectal area and drape the patient.
- Cover the rectal probe with a lubricated condom and insert it into the rectum. Inform the patient that he may feel slight pressure as the transducer is inserted. Water may be introduced through the sheath surrounding the transducer.
- Ask the patient to breathe normally during the examination. If necessary for better organ visualization, ask the patient to inhale deeply and hold his breath.
- Inform the patient that a report of the results will be made available to the requesting HCP, who will discuss the results with the patient.
- When the study is completed, remove the gel from the skin.
- Nutritional Considerations: There is growing evidence that inflammation and oxidation play key roles in the development of numerous diseases, including prostate cancer. Research also indicates that diets containing dried beans, fresh fruits and vegetables, nuts, spices, whole grains, and smaller amounts of red meats can increase the amount of protective antioxidants. Regular exercise, especially in combination with a healthy diet, can bring about changes in the body’s metabolism that decrease inflammation and oxidation.
- Recognize anxiety related to test results. Discuss the implications of abnormal test results on the patient’s lifestyle. Provide teaching and information regarding the clinical implications of the test results, as appropriate. Administer antibiotics as ordered, after biopsy. Educate the patient regarding access to counseling services. Provide contact information, if desired, for the National Cancer Institute (www.cancer.gov) or the Prostate Cancer Foundation (www.prostatecancerfoundation.org).
- Reinforce information given by the patient’s HCP regarding further testing, treatment, or referral to another HCP. Answer any questions or address any concerns voiced by the patient or family. Decisions regarding the need for and frequency of routine PSA testing or other cancer screening procedures should be made after consultation between the patient and HCP. Recommendations made by various medical associations and national health organizations regarding prostate cancer screening are moving away from routine PSA screening and toward informed decision making. The American Cancer Society’s (ACS) guidelines recommend that discussions about screening should begin at age 50 yr for men at average risk, 45 yr for men at high risk, and 40 yr for men at the highest risk of developing prostate cancer. The most current guidelines for prostate cancer screening of the general population as well as of individuals with increased risk are available from the ACS (www.cancer.org) and the American Urological Association (www.aua.org).
- Depending on the results of this procedure, additional testing may be needed to evaluate or monitor progression of the disease process and determine the need for a change in therapy. Evaluate test results in relation to the patient’s symptoms and other tests performed.
- Related tests include biopsy prostate, CT pelvis, cystoscopy, cystourethrography voiding, IVP, KUB study, MRI pelvis, proctosigmoidoscopy, PSA, renogram, retrograde ureteropyelography, and semen analysis.
- Refer to the Genitourinary System table at the end of the book for related tests by body system.